Biotechnology Healthcare - September/October 2008 - (Page 5) Confidence that breast cancer treatment is tailored for her. Oncotype DX® is the leading clinically validated, multi-gene assay that quantifies the likelihood of distant breast cancer recurrence. It delivers: • An Individualized Recurrence Score™ Result — Based on the expression of 21 genes from a sample of a patient’s tumor tissue • A Chemotherapy Benefit Assessment — Predicts the magnitude of benefit from chemotherapy • Confidence — Performance exceeds standard measures such as tumor size, tumor grade, and patient age in terms of either predictive power or reproducibility Strength in Numbers Learn how Oncotype DX can provide valuable insight when making adjuvant therapy decisions at www.oncotypeDX.com, or call (866) ONCOTYPE (866-662-6897). Oncotype DX is a registered trademark and Recurrence Score is a trademark of Genomic Health, Inc. ©2008 Genomic Health, Inc. All rights reserved. 3/08 http://www.oncotypeDX.com http://www.oncotypeDX.com
Table of Contents Feed for the Digital Edition of Biotechnology Healthcare - September/October 2008 Biotechnology Healthcare - September/October 2008 Openers Editorial/David B. Nash, MD, MBA Contents At a Glance: Multiple Sclerosis Drug Track Personalized Medicine Healthcare Reform’s Effects on Biologic Access Breast Cancer Status Testing: A Crapshoot With Deadly Odds Trends, Issues, and Perspectives In the Management of MS So High-Tech, Yet So Simple The Evolution of Ascertaining the Value Proposition Specialty Pharmacy Employer to Employer Health Plan Confidential Trends Biotechnology Healthcare - September/October 2008 Biotechnology Healthcare - September/October 2008 - Biotechnology Healthcare - September/October 2008 (Page CoverA) Biotechnology Healthcare - September/October 2008 - Biotechnology Healthcare - September/October 2008 (Page CoverB) Biotechnology Healthcare - September/October 2008 - Biotechnology Healthcare - September/October 2008 (Page CoverC) Biotechnology Healthcare - September/October 2008 - Biotechnology Healthcare - September/October 2008 (Page CoverD) Biotechnology Healthcare - September/October 2008 - Biotechnology Healthcare - September/October 2008 (Page 1) Biotechnology Healthcare - September/October 2008 - Openers (Page 2) Biotechnology Healthcare - September/October 2008 - Editorial/David B. Nash, MD, MBA (Page 3) Biotechnology Healthcare - September/October 2008 - Contents (Page 4) Biotechnology Healthcare - September/October 2008 - Contents (Page 5) Biotechnology Healthcare - September/October 2008 - At a Glance: Multiple Sclerosis (Page 6) Biotechnology Healthcare - September/October 2008 - At a Glance: Multiple Sclerosis (Page 7) Biotechnology Healthcare - September/October 2008 - Drug Track (Page 8) Biotechnology Healthcare - September/October 2008 - Drug Track (Page 9) Biotechnology Healthcare - September/October 2008 - Drug Track (Page 10) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 11) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 12) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 13) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 14) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 15) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 16) Biotechnology Healthcare - September/October 2008 - Personalized Medicine (Page 17) Biotechnology Healthcare - September/October 2008 - Healthcare Reform’s Effects on Biologic Access (Page 18) Biotechnology Healthcare - September/October 2008 - Healthcare Reform’s Effects on Biologic Access (Page 19) Biotechnology Healthcare - September/October 2008 - Healthcare Reform’s Effects on Biologic Access (Page 20) Biotechnology Healthcare - September/October 2008 - Healthcare Reform’s Effects on Biologic Access (Page 21) Biotechnology Healthcare - September/October 2008 - Healthcare Reform’s Effects on Biologic Access (Page 22) Biotechnology Healthcare - September/October 2008 - Breast Cancer Status Testing: A Crapshoot With Deadly Odds (Page 23) Biotechnology Healthcare - September/October 2008 - Breast Cancer Status Testing: A Crapshoot With Deadly Odds (Page 24) Biotechnology Healthcare - September/October 2008 - Breast Cancer Status Testing: A Crapshoot With Deadly Odds (Page 25) Biotechnology Healthcare - September/October 2008 - Breast Cancer Status Testing: A Crapshoot With Deadly Odds (Page 26) Biotechnology Healthcare - September/October 2008 - Breast Cancer Status Testing: A Crapshoot With Deadly Odds (Page 27) Biotechnology Healthcare - September/October 2008 - Breast Cancer Status Testing: A Crapshoot With Deadly Odds (Page 28) Biotechnology Healthcare - September/October 2008 - Trends, Issues, and Perspectives In the Management of MS (Page 29) Biotechnology Healthcare - September/October 2008 - Trends, Issues, and Perspectives In the Management of MS (Page 30) Biotechnology Healthcare - September/October 2008 - Trends, Issues, and Perspectives In the Management of MS (Page 31) Biotechnology Healthcare - September/October 2008 - Trends, Issues, and Perspectives In the Management of MS (Page 32) Biotechnology Healthcare - September/October 2008 - Trends, Issues, and Perspectives In the Management of MS (Page 33) Biotechnology Healthcare - September/October 2008 - Trends, Issues, and Perspectives In the Management of MS (Page 34) Biotechnology Healthcare - September/October 2008 - So High-Tech, Yet So Simple (Page 35) Biotechnology Healthcare - September/October 2008 - So High-Tech, Yet So Simple (Page 36) Biotechnology Healthcare - September/October 2008 - So High-Tech, Yet So Simple (Page 37) Biotechnology Healthcare - September/October 2008 - So High-Tech, Yet So Simple (Page 38) Biotechnology Healthcare - September/October 2008 - The Evolution of Ascertaining the Value Proposition (Page 39) Biotechnology Healthcare - September/October 2008 - The Evolution of Ascertaining the Value Proposition (Page 40) Biotechnology Healthcare - September/October 2008 - The Evolution of Ascertaining the Value Proposition (Page 41) Biotechnology Healthcare - September/October 2008 - The Evolution of Ascertaining the Value Proposition (Page 42) Biotechnology Healthcare - September/October 2008 - Specialty Pharmacy (Page 43) Biotechnology Healthcare - September/October 2008 - Specialty Pharmacy (Page 44) Biotechnology Healthcare - September/October 2008 - Employer to Employer (Page 45) Biotechnology Healthcare - September/October 2008 - Employer to Employer (Page 46) Biotechnology Healthcare - September/October 2008 - Health Plan Confidential (Page 47) Biotechnology Healthcare - September/October 2008 - Health Plan Confidential (Page 48) Biotechnology Healthcare - September/October 2008 - Trends (Page 49)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.